LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 56 of 497
Next
>>
>
1376 to 1400 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	YM 201636	1.11	uM	LJP5	2	N09	72	hr	1097	3043	3769	0.8073	0.7281
BT-20	YM 201636	1.11	uM	LJP5	3	N09	72	hr	1097	2797	3769	0.7420	0.6361
BT-20	ZSTK474	1.11	uM	LJP6	1	M15	72	hr	1097	1231	3769	0.3266	0.0500
BT-20	ZSTK474	1.11	uM	LJP6	2	M15	72	hr	1097	1180	3769	0.3130	0.0310
BT-20	ZSTK474	1.11	uM	LJP6	3	M15	72	hr	1097	1201	3769	0.3186	0.0388
BT-20	Afatinib	3.33	uM	LJP6	1	G20	72	hr	1097	3204	3769	0.8500	0.7884
BT-20	Afatinib	3.33	uM	LJP6	2	G20	72	hr	1097	3264	3769	0.8659	0.8108
BT-20	Afatinib	3.33	uM	LJP6	3	G20	72	hr	1097	3292	3769	0.8733	0.8213
BT-20	Sigma A6730	3.33	uM	LJP5	1	B20	72	hr	1097	3275	3769	0.8688	0.8149
BT-20	Sigma A6730	3.33	uM	LJP5	2	B20	72	hr	1097	3417	3769	0.9065	0.8681
BT-20	Sigma A6730	3.33	uM	LJP5	3	B20	72	hr	1097	3310	3769	0.8781	0.8280
BT-20	Alvocidib	3.33	uM	LJP6	1	A14	72	hr	1097	680	3769	0.1804	-0.1561
BT-20	Alvocidib	3.33	uM	LJP6	2	A14	72	hr	1097	646	3769	0.1714	-0.1689
BT-20	Alvocidib	3.33	uM	LJP6	3	A14	72	hr	1097	580	3769	0.1539	-0.1936
BT-20	AT-7519	3.33	uM	LJP6	1	K02	72	hr	1097	445	3769	0.1181	-0.2441
BT-20	AT-7519	3.33	uM	LJP6	2	K02	72	hr	1097	705	3769	0.1870	-0.1468
BT-20	AT-7519	3.33	uM	LJP6	3	K02	72	hr	1097	470	3769	0.1247	-0.2347
BT-20	AZD 5438	3.33	uM	LJP6	1	J02	72	hr	1097	796	3769	0.2112	-0.1127
BT-20	AZD 5438	3.33	uM	LJP6	2	J02	72	hr	1097	774	3769	0.2053	-0.1210
BT-20	AZD 5438	3.33	uM	LJP6	3	J02	72	hr	1097	715	3769	0.1897	-0.1430
BT-20	AZD-6482	3.33	uM	LJP5	1	I02	72	hr	1097	1295	3769	0.3435	0.0740
BT-20	AZD-6482	3.33	uM	LJP5	2	I02	72	hr	1097	1578	3769	0.4186	0.1799
BT-20	AZD-6482	3.33	uM	LJP5	3	I02	72	hr	1097	1455	3769	0.3860	0.1339
BT-20	AZD7762	3.33	uM	LJP6	1	L02	72	hr	1097	714	3769	0.1894	-0.1434
BT-20	AZD7762	3.33	uM	LJP6	2	L02	72	hr	1097	794	3769	0.2106	-0.1135

|<
<<
Previous
Page 56 of 497
Next
>>
>
1376 to 1400 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)